These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8949461)

  • 21. Dupilumab probably reduces transepidermal water loss but does not increase stratum corneum hydration in atopic dermatitis.
    Furuhashi T; Oda T; Torii K; Nishida E; Morita A
    J Dermatol; 2021 Feb; 48(2):e74-e75. PubMed ID: 33035368
    [No Abstract]   [Full Text] [Related]  

  • 22. [Calmuril-hydrocortisone and carbamide-hydrocortisone DAK. A comparison in the treatment of atopic dermatitis].
    Andersen KE; Brandrup F; Jacobsen M
    Ugeskr Laeger; 1979 Dec; 141(51):3512-4. PubMed ID: 395746
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of percutaneous absorption of hydrocortisone on adrenocortical responsiveness in infants with severe skin disease.
    Turpeinen M; Salo OP; Leisti S
    Br J Dermatol; 1986 Oct; 115(4):475-84. PubMed ID: 2946314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis.
    Sator PG; Schmidt JB; Hönigsmann H
    J Am Acad Dermatol; 2003 Mar; 48(3):352-8. PubMed ID: 12637914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantifying systemic absorption of topical hydrocortisone in erythroderma.
    Aalto-Korte K; Turpeinen M
    Br J Dermatol; 1995 Sep; 133(3):403-8. PubMed ID: 8546995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased skin pH and transepidermal water loss may serve as predictor for atopic dermatitis flares.
    Marini A; Aue N; Demessant AL; Salah S; Kerob D; Luger TA
    J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):e252-e254. PubMed ID: 35993494
    [No Abstract]   [Full Text] [Related]  

  • 27. Atopic dermatitis: correlation between non-damaged skin barrier function and disease activity.
    Addor FA; Takaoka R; Rivitti EA; Aoki V
    Int J Dermatol; 2012 Jun; 51(6):672-6. PubMed ID: 22607284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of skin barrier emulsion cream vs a conventional moisturizer on transepidermal water loss and corneometry in atopic dermatitis: a pilot study.
    Kircik LH
    J Drugs Dermatol; 2014 Dec; 13(12):1482-4. PubMed ID: 25607793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of atopic eczema: clinical scoring and noninvasive measurements.
    Holm EA; Wulf HC; Thomassen L; Jemec GB
    Br J Dermatol; 2007 Oct; 157(4):674-80. PubMed ID: 17672874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal steroid responsiveness in atopic dermatitis patients: therapeutic implications.
    Charlesworth EN
    Ann Allergy Asthma Immunol; 2000 Jul; 85(1):3-4. PubMed ID: 10923597
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hydrocortisone-17-butyrate (0.1 percent) versus hydrocortisone acetate (1 percent) in atopic dermatitis. Controlled double-blind study of 20 children].
    Giannetti A; Laria G; Seidenari S
    Minerva Pediatr; 1981 Jun; 33(12):597-600. PubMed ID: 7022158
    [No Abstract]   [Full Text] [Related]  

  • 32. Adrenal function following topical steroid treatment in children with atopic dermatitis.
    Patel L; Clayton PE; Addison GM; Price DA; David TJ
    Br J Dermatol; 1995 Jun; 132(6):950-5. PubMed ID: 7662574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transonychial water loss in healthy and diseased nails.
    Krönauer C; Gfesser M; Ring J; Abeck D
    Acta Derm Venereol; 2001; 81(3):175-7. PubMed ID: 11558871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of pimecrolimus compared with triamcinolone acetonide cream on skin barrier structure in atopic dermatitis: a randomized, double-blind, right-left arm trial.
    Jensen JM; Weppner M; Dähnhardt-Pfeiffer S; Neumann C; Bräutigam M; Schwarz T; Fölster-Holst R; Proksch E
    Acta Derm Venereol; 2013 Sep; 93(5):515-9. PubMed ID: 23571785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skin barrier integrity and natural moisturising factor levels after cumulative dermal exposure to alkaline agents in atopic dermatitis.
    Angelova-Fischer I; Dapic I; Hoek AK; Jakasa I; Fischer TW; Zillikens D; Kezic S
    Acta Derm Venereol; 2014 Nov; 94(6):640-4. PubMed ID: 24531413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis.
    Werner Y; Lindberg M
    Acta Derm Venereol; 1985; 65(2):102-5. PubMed ID: 2408409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled trial of the treatment of atopic eczema with a urea-hydrocortisone preparation versus betamethasone 17-valerat.
    Almeyda J; Fry L
    Br J Dermatol; 1973 May; 88(5):493-5. PubMed ID: 4715126
    [No Abstract]   [Full Text] [Related]  

  • 38. Hydrocortisone butyrate 0.1% cream (proprietary lipid rich cream vehicle) does not significantly suppress hypothalamic-pituitary-adrenal axis and is effective in pediatric patients 3 months and older with extensive atopic dermatitis.
    Abramovits W; Oquendo M
    Skinmed; 2010; 8(3):150-4. PubMed ID: 21137620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of hydration, sebum and pH values in clinically normal skin of patients with atopic dermatitis and healthy controls.
    Firooz A; Gorouhi F; Davari P; Atarod M; Hekmat S; Rashighi-Firoozabadi M; Solhpour A
    Clin Exp Dermatol; 2007 May; 32(3):321-2. PubMed ID: 17335552
    [No Abstract]   [Full Text] [Related]  

  • 40. Transepidermal water loss on the hands in atopic dermatitis.
    Rajka G
    Arch Dermatol Forsch; 1974; 251(2):111-5. PubMed ID: 4447381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.